Peter Greenberg

Hematologist, Medical oncologist, Leukemia specialist

Bio:   Dr Greenberg’s laboratory research focuses on evaluating molecular abnormalities in myelodysplastic syndromes (MDS) with specific interest in gene expression profiling of marrow stem and progenitor cells using RNA Seq and microarray methodologies and proteomic analysis of aberrant antigen expression in plasma. As Director of the Stanford MDS Center his clinical research involves design and coordination of clinical trials using experimental drugs with biologic focus for both lower and higher risk MDS patients not responding to standard therapies. He is Coordinator of the International Working Group for Prognosis in MDS (IWG-PM) which generated the IPSS-R and is now evaluating the impact of molecular mutations on this risk-based prognostic system. He is Chair of the NCCN Practice Guidelines Panel for MDS.
4.8 out of 5
52 Patient Ratings
3 Patient Comments

Cancer Center

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
More Clinic Information » Insurance Coverage » Getting Here » Make An Appointment

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
More Clinic Information » Insurance Coverage » Getting Here » Make An Appointment

Professional Education

  • Medical Education: George Washington University (1963) DC
  • Fellowship: Stanford University School of Medicine (1971) CA
  • Residency: Barnes Hospital (1965) MO
  • Residency: Stanford University School of Medicine (1968) CA
  • Board Certification: Hematology, American Board of Internal Medicine (1976)
  • Board Certification: Internal Medicine, American Board of Internal Medicine (1970)
  • Internship: Barnes Hospital (1964) MO
  • B.A., Johns Hopkins University, Biological Sciences (1959)
  • M.D., George Washington U Med School, Medicine (1963)

Honors & Awards

  • International Prize for outstanding research in myelodysplastic syndromes (MDS), J.P. McCarthy Foundation (1997)

Administrative Appointments

  • Coordinator, International Working Group for Prognosis in MDS (2009 - 2015)
  • Chair, National Comprehensive Cancer Network Myelodysplasitic Syndromes Practice Guidelines Panel (1997 - 2015)
  • Director, Stanford MDS Center (1998 - 2015)
  • Head, Hematology Section, VA Palo Alto Health Care System (1979 - 2005)
  • Acting Chief, Medical Service, VA Palo Alto Health Care System (1978 - 1979)

Patient Ratings and Comments

4.8

Friendliness

4.8

Recommended to others

4.8

Explanations

4.8

Listens

4.6

Includes you in decisions

4.8

Clear Communication

4.8

Confidence in your doctor

4.1

Wait times

SHC Patient, May 2014

Extremely compassionate and caring putting patient at ease.

SHC Patient, May 2014

He was considerate encouraging & seemed interested in me & he told me I could call him!

SHC Patient, Apr 2014

Dr. Greenberg provided an excellent support. Thanks to him.

4.8 out of 5
52 Patient Ratings
3 Patient Comments

SHC Patient, May 2014

Extremely compassionate and caring putting patient at ease.

SHC Patient, May 2014

He was considerate encouraging & seemed interested in me & he told me I could call him!

SHC Patient, Apr 2014

Dr. Greenberg provided an excellent support. Thanks to him.